Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Safety

Por Dobesh, Paul P, Oestreich, Julie H
Publicado no Pharmacotherapy (2014)

Platelet Function Analysis: at the edge of meaning

Por Oestreich, Julie H., Smyth, Susan, Campbell, Charles
Publicado em 2009

Pharmacodynamic interplay of the P2Y(1), P2Y(12), and TxA(2) pathways in platelets: the potential of triple antiplatelet therapy with P2Y(1) receptor antagonism

Por Oestreich, Julie H., Ferraris, Suellen P., Steinhubl, Steven R., Akers, Wendell S.
Publicado em 2012

Impact of genetic polymorphisms on clinical response to antithrombotics

Por Lanham, Kena J, Oestreich, Julie H, Dunn, Steven P, Steinhubl, Steven R
Publicado em 2010

Impact of a high-fat meal on assessment of clopidogrel-induced platelet inhibition in healthy subjects

Por Dobesh, Paul P, Urban, Jamela F, Shurmur, Scott W, Oestreich, Julie H
Publicado no Thromb J (2015)

Considerable Variability in Platelet Activity among Patients with Coronary Artery Disease in Response to an Increased Maintenance Dose of Clopidogrel

Por Oestreich, Julie H., Holt, John, Dunn, Steven P., Smyth, Susan S., Campbell, Charles L., Charnigo, Richard, Akers, Wendell S., Steinhubl, Steven R.
Publicado em 2009